Send us Feedback

Pfizer (PFE)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

 
Annual Reports

  • 10-K (Mar 1, 2013)
  • 10-K (Feb 28, 2013)
  • 10-K (Feb 28, 2012)
  • 10-K (Feb 28, 2011)
  • 10-K (Feb 26, 2010)
  • 10-K (Feb 27, 2009)

 
Quarterly Reports

 
8-K

 
Other

Pfizer 10-K 2009

Documents found in this filing:

  1. Form 10-K
  2. Annual Retainer Unit Award Plan
  3. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors
  4. Computation of Ratio of Earnings To Fixed Charges
  5. Portions of the 2008 Financial Report
  6. Subsidiaries of the Company
  7. Consent of Kpmg Llp, Independent Registered Public Accounting Firm
  8. Certification By the Chief Executive Officer Pursuant To Section 302
  9. Certification By the Chief Financial Officer Pursuant To Section 302
  10. Certification By the Chief Executive Officer Pursuant To Section 906
  11. Certification By the Chief Financial Officer Pursuant To Section 906
  12. Graphic
  13. Graphic
  14. Graphic
  15. Graphic
  16. Graphic
  17. Graphic
  18. Graphic
  19. Complete submission text file
Computation of Ratio of Earnings to Fixed Charges

Exhibit 12

PFIZER INC. AND SUBSIDIARY COMPANIES

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

 

     Year Ended December 31,

(in millions, except ratios)

    2008    2007    2006    2005    2004

Determination of earnings:

               

Income from continuing operations before provision for taxes on income, minority interests and cumulative effect of a change in accounting principles

    $ 9,694    $ 9,278    $ 13,028    $ 10,800    $ 13,403

Less:

               

Minority interests

      23      42      12      12      7
                                  

Income adjusted for minority interests

      9,671      9,236      13,016      10,788      13,396

Add:

               

Fixed charges

      647      541      642      622      505
                                  

Total earnings as defined

    $ 10,318    $ 9,777    $ 13,658    $ 11,410    $ 13,901
                                  

Fixed charges:

               

Interest expense(a)

    $ 516    $ 397    $ 488    $ 471    $ 347

Preferred stock dividends(b)

      8      11      14      14      12

Rents(c)

      123      133      140      137      146
                                  

Fixed charges

      647      541      642      622      505

Capitalized interest

      46      43      29      17      12
                                  

Total fixed charges

    $ 693    $ 584    $ 671    $ 639    $ 517
                                  

Ratio of earnings to fixed charges

      14.9      16.7      20.4      17.9      26.9
                                  

All financial information reflects the following as discontinued operations for 2006, 2005 and 2004: the Consumer Healthcare business; certain European generics businesses; and for 2004: our in-vitro allergy and autoimmune diagnostics testing, and surgical ophthalmics.

 

(a)

Interest expense includes amortization of debt premium, discount and expenses. Interest expense does not include interest related to uncertain tax positions of $333 million for 2008; $331 million for 2007; $200 million for 2006; $203 million for 2005; and $201 million for 2004.

 

(b)

Preferred stock dividends are from our Series A convertible perpetual preferred stock held by an Employee Stock Ownership Plan assumed in connection with our acquisition of Pharmacia in 2003.

 

(c)

Rents included in the computation consist of one-third of rental expense, which we believe to be a conservative estimate of an interest factor in our leases, which are not material.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki